Millennium's Dunsire named as first woman on Takeda board; Medivir collaboration focuses on new drugs to combat antibiotic-resistant bacteria;

 @FierceBiotech: Ultrasound pill could replace daily injections. More | Follow @FierceBiotech

 @JohnCFierce: The cliffhanger: FDA set to decide on Arena's lorcaserin - (I suspect it's yes, but I wouldn't be flabbergasted by delay). Story | Follow @JohnCFierce

 @RyanMFierce: Why mobile tech isn't ideal for recruitment in clinical trials. More | Follow @RyanMFierce

> Millennium Pharmaceuticals CEO Deborah Dunsire has won a board position at Takeda. She's only the third non-Japanese citizen and the first woman to gain a seat on the board of Takeda, which owns Millennium. Report

> Beverly, MA-based Cellceutix has won FDA approval to launch a Phase I study of its experimental cancer drug Kevetrin. Story

> Sweden's Medivir AB has launched a collaboration with researchers at the Swedish University of Agricultural Sciences aimed at identifying and developing new drugs against antibiotic-resistant bacteria. Release

> Shares of Israel's Prolor jumped on positive Phase II data for its weekly growth hormone treatment. Story

Pharma News

 @FiercePharma: S&P gives Novartis props for R&D productivity, cites "good chance" of "at least stable" sales despite Diovan loss. Report | Follow @FiercePharma

> Merck, AstraZeneca rejig stomach-drug partnership. Story

> PDUFA goes to the president. News

> Amylin shareholder sues board for self-enrichment. News

Medical Devices News 

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Top 10 Medical Devices CEO Salaries of 2011. Special Report

> Lab21, mystery pharma partner to launch colon cancer companion Dx in 2012. More

> Infraredx penetrates Japanese mkt with $50M Nipro deal. News

> Ohio devicemaker adding jobs after $5M tax break. Article

Drug Delivery News

 @DamianFierce: With the diabetes market burgeoning around the globe, Fierce takes a look at the top 5 insulin-delivery techs to watch. Special Report | Follow @DamianFierce

> Nanoparticles could help block herpes infection. News

> Cholesterol boosts cancer nanotherapy. Article

> Researchers cook up sugar-based capsules for drug delivery. Item

> West teams with Amgen for injectable delivery. Story

Biomarkers News

> Pregnancy biomarkers linked with long-term cardiovascular risk. Story

> Biomarker might cut unneeded thyroid surgery. Article

> Alzheimer's blood test moves closer. News

> FDA approves Beckman Coulter's prostate blood test. More

And Finally… Lund University investigators have been tracking how Parkinson's disease spreads through the brain in a process in which misfolded proteins travel from sick to healthy cells, much like Mad Cow disease. Release

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.